Search Results for

The initial series served as a reminder of the first Trump administration’s utter indifference to the public interest. This time around, the Revolving Door Project will be on hand to provide real time, clear-eyed analyses of the President-elect’s approach towards governance, staffing, ethics and critically, the material impact of his pro-corporate attitudes. 

The Hatch-Waxman Act, despite its intentions, has become a monopoly-extending machine that prioritizes pharmaceutical profits over public health. A 40th birthday is a good chance for anyone to rethink where their life is headed — and major legislation is no exception.

As election season heats up, it’s critical for reporters and editors to pair fresh coverage with clear reminders of the candidates’ records of administering the executive branch. An honest representation of these records would show how Trump and his hand-picked leadership treated the federal government as either their personal fief or a conduit for institutionalizing corporate interests.

The memos, which cover a broad range of themes, including disaster and emergency management, labor, housing, transportation, financial regulation and more, highlight the myriad ways the former president and his cast of conflicted appointees prioritized corporate interests while jeopardizing the health, safety and wellbeing of the American people.

Biden erred with his renomination of Powell, but if he gets another chance, he must choose a central bank leader dedicated to properly tackling the myriad challenges facing the Fed, which range from price stability and full employment to financial stability and climate-related financial risk.

The patent system exists to promote scientific innovation to benefit the public, not to enrich private interests regardless of the merits of their scientific contributions. Yet that is precisely what PERA and PREVAIL would do by granting Big Pharma even more sweeping government monopolies and associated price-gouging power.

Accounting’s technical jargon makes the industry obscure to most Americans. It’s likely your next-door neighbor has no idea of the PCAOB’s activities, its responsibility to protect investors, or its history of negligence. That’s expected, but chair Williams is now working to turn the ship around to fix the shortcomings of one of America’s most consequential oligopolies, and it will improve the economic lives of an unaware public.

More problematically, conflicts of interest have plagued the USPTO, including at the highest levels. Trump-era USPTO director Andrei Iancu was far too cozy with patent law firms while he served in government. Iancu came in via the revolving door from patent litigation firm Irell & Manella, where he earned $4,733,748 as a managing partner in the year before he was nominated, and went out the door and back to the firm when his term was up. He is now a partner in Sullivan & Cromwell’s patent practice.

As long as one party remains totally united behind a man who attempted to overthrow the government by force, was the most corrupt president in American history, and undermines the public’s faith in elections at every turn, the future of American democratic self-government is at risk.

Sounds scary. But what if I told you this was a great opportunity for fun and profit? Silicon Valley–backed startup Kalshi is attempting to expand the amount of gambling on the country’s elections with the introduction of an “event contract” centered around congressional elections. Simply put, the firm aims to allow traders to bet on the event: Which party will win control of Congress?

If we were to agree to the industry’s demand that policy experts should be precluded from regulating issues they have spent significant amounts of time developing expertise in, we would be setting a precedent that severely undermines any kind of public-minded enforcement. In fact, banning experts such as Gensler would leave the public with a pool of potential regulators who are either already corporate-aligned or unqualified to adequately opine on pressing issues.